Decan

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Decan

Quick Facts

Property Description
Active ingredient Dexamethasone
Form Oral tablet, injectable solution, drops, nasal spray
Pharmacological class Corticosteroid (Glucocorticoid)
Common purpose Anti-inflammatory and immunosuppressive action
Origin Synthetic

What Type of Medicine is Decan (Dexamethasone)?

Decan is a prescription medication defined by its active ingredient, Dexamethasone, which is classified as a potent synthetic adrenocortical steroid. It belongs to the broader pharmacological class of Corticosteroids, specifically categorized as a Glucocorticoid. Dexamethasone is chemically distinct as a fluorinated glucocorticoid, meaning it is a chemically engineered derivative designed to replicate and enhance the actions of naturally occurring hormones like cortisol. Dexamethasone is widely used for its potent anti-inflammatory effects and low risk of causing significant electrolyte imbalance compared to some other steroids. This means the medicine is highly focused on controlling swelling and immune responses while having minimal interference with the body's salt and water regulation.

Composition, Forms, and General Purpose

Decan is prepared as a single-ingredient product, available in multiple pharmaceutical preparations, including oral tablets, oral solutions, injectable solutions (such as the salt form Dexamethasone sodium phosphate), and specialized eye drops. The fundamental composition centers on the active Dexamethasone compound, combined with an appropriate base/vehicle necessary for the intended route of administration. The general purpose of this medicine is to function as a powerful anti-inflammatory agent and immunosuppressive agent. Its primary action is to reduce the body's response to inflammation and modify the immune response. In simple terms, this medicine works to calm down the overactive or damaging swelling and defensive reactions of the body. For instance, a typical therapeutic use scenario might involve its application to control severe allergic or inflammatory symptoms where a rapid, powerful anti-inflammatory response is required.

Regulatory References

  1. Dexamethasone: StatPearls
  2. Dexamethasone: MedlinePlus Drug Information

What side effects are possible with Decan?

Possible Side Effects and Safety Information

The safety profile of Decan is documented based on authoritative government regulatory sources, which classify adverse reactions according to their frequency and the body system affected.


Adverse Reactions Scope

Adverse drug reactions (ADRs) are categorized using standardized frequency bands (e.g., Very Common, Common, Uncommon, Rare). Common side effects generally include Nausea and Vomiting (Gastrointestinal Disorders) and Headache (Nervous System Disorders).

  • System-Organ Classes Involved: Adverse effects are formally grouped into categories such as Gastrointestinal Disorders, Nervous System Disorders, Hepatobiliary Disorders, and Immune System Disorders.

  • Serious Adverse Reactions: The label highlights the possibility of rare but clinically significant reactions, including Severe Hepatic Failure, Angioedema, and Agranulocytosis.

  • Dose- or Exposure-Related Patterns: Regulatory data states that the risk of gastrointestinal irritation is highest during the first week of treatment, and a higher incidence of peripheral neuropathy is noted with treatment duration exceeding six months.


Safety Restrictions and Monitoring

Decan is subject to specific safety limitations and monitoring protocols as defined in the official prescribing information:

  • Contraindications: Use is strictly restricted in patients with known hypersensitivity to Decan or its excipients, and it is contraindicated in patients with severe hepatic impairment (Child-Pugh Class C).

  • Mandatory Monitoring: Periodic liver function tests (e.g., every four weeks for the first six months) and complete blood counts (CBC) are required to monitor safety during therapy. A dosage adjustment is required for patients with creatinine clearance below 30 mL/min.

These restrictions and mandatory monitoring requirements are in place to manage known risks and ensure the medicine's use is within the documented safety framework.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Decan (Dexamethasone) overdose is characterized by the exaggeration of known glucocorticoid effects. Documented clinical manifestations primarily involve fluid and electrolyte disturbances, including hypertension (elevated blood pressure), sodium and water retention (edema), and excessive potassium loss (hypokalemia). Severe central nervous system presentations such as convulsions and psychotic reactions are also officially noted in product labeling.

Overdose exposure carries the risk of life-threatening severe outcomes. The label documents potential progression to shock or coma if high-dose administration is abruptly discontinued, stressing the risk of acute adrenal insufficiency. Regulators have also reported rare but severe complications, including fatal pheochromocytoma crisis and Tumour Lysis Syndrome (TLS).

Immediate medical attention is formally mandated if an overdose is suspected. Government guidance explicitly states that emergency services must be contacted immediately if the affected person has collapsed, experienced a seizure, or cannot be awakened. Treatment is designated as strictly symptomatic and supportive, as no specific pharmacological antidote is documented. Management focuses on the correction of severe, documented clinical and laboratory abnormalities, such as severe electrolyte imbalances and instability of vital signs.

Therapeutic Uses of Decan

What Decan Treats: Main Uses and Benefits

Decan is commonly used across domains where short-term symptomatic assistance is appropriate, serving as a supportive symptomatic management tool. It is relevant in clinical settings that involve acute or unstable symptom patterns, helping address symptom clusters that may become intense or disruptive.

This medicine is applied across conditions characterized by periods of heightened symptoms, including severe allergic reactions, acute flare-ups of rheumatic disorders (like lupus), certain blood cancers (such as multiple myeloma), and to manage cerebral edema (brain swelling). It is also relevant for conditions, such as adrenal insufficiency.

Relief from Severe Systemic Inflammation and Acute Episodes

Decan is commonly used for short-term support in managing the pronounced symptoms associated with acute episodes. It is applied in contexts where conditions involve symptoms related to inflammation, such as swelling, heat, and pain, or where airway obstruction is a concern. The medication may assist with easing symptoms caused by localized swelling in neurological conditions and supports patients during difficult episodes.

“This medication is applied in scenarios where additional management of discomfort is required, helping ease the overall symptom burden.”


Quick Fact: Relief for Inflammation and Swelling

Focus Area Symptom Context Benefit Provided
Systemic Inflammation Acute flare-ups of autoimmune conditions and severe allergies. Contributes to improved comfort during symptomatic periods.
Neurological Distress Symptoms related to brain swelling (cerebral edema) due to tumors. Supports general well-being and may assist with maintaining functional stability.
Airway Edema Incapacitating asthma or croup in children. Assists with managing symptoms that interfere with daily functioning.

Regulatory References

  1. DEXAMETHASONE tablet - DailyMed - NIH

Eligibility and Restrictions for Use

Who Can and Cannot Use Decan?

Eligibility for Decan (Dexamethasone) is defined by official regulatory labeling, primarily concerning absolute prohibitions and conditions requiring careful monitoring. The medicine is broadly available for use in adults and children unless specific non-eligibility rules apply.


Absolute Non-Eligibility

Decan is contraindicated and must not be used in the following populations:

  • Patients with Systemic Fungal Infections.
  • Individuals with a known Hypersensitivity (allergy) to Dexamethasone or any component of the product.
  • Patients on Immunosuppressive Doses who require Live or Live, Attenuated Vaccines.

Conditional Use and Restrictions

Certain populations and pre-existing conditions require specific caution or restriction, as documented in official prescribing information:

Population/Condition Regulatory Requirement
Pregnancy Use is restricted; benefit must justify potential risk to the fetus.
Breastfeeding Not recommended due to drug transfer into breast milk.
Pediatric Use Requires monitoring for growth suppression during long-term therapy.
Cardiovascular/Renal Issues Use with caution in patients with Congestive Heart Failure or Hypertension.
Infectious Risk Patients with Latent Tuberculosis or Active Ocular Herpes Simplex require special considerations or contraindication.

Eligibility hinges on the absence of formal contraindications and the necessity of closely managing underlying conditions.

What should I know about interactions with other medicines?

Decan (dexamethasone) interacts with numerous medicines primarily through its metabolism via the CYP 3A4 enzyme in the liver. Products that induce CYP 3A4, such as certain anticonvulsants (e.g., phenytoin, carbamazepine) and antituberculars (e.g., rifampin), can increase the breakdown of Decan, potentially reducing its effectiveness. Conversely, strong CYP 3A4 inhibitors, including specific macrolide antibiotics (e.g., clarithromycin) and antifungals (e.g., ketoconazole), can slow down Decan's metabolism, increasing its concentration and the risk of systemic side effects.

Pharmacodynamic interactions also occur. Combining Decan with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen or aspirin, may significantly increase the risk of gastrointestinal bleeding and ulceration. Since Decan can elevate blood glucose levels, the required dosage for antidiabetic agents (e.g., insulin, metformin) may need adjustment. Concomitant use with potassium-depleting agents (e.g., diuretics, Amphotericin B) increases the risk of low potassium (hypokalemia).

Live or live-attenuated vaccines are generally contraindicated during treatment with Decan due to its immunosuppressive effects, which could diminish the vaccine's effectiveness and increase the risk of disseminated infection. Effects on anticoagulants, such as warfarin, can be variable and require frequent blood monitoring. Estrogens, including oral contraceptives, may also increase Decan concentrations in the body.

Mechanism of Action

How Decan Works

Decan operates through a multi-domain mechanistic profile, engaging key signaling pathways to modify physiological responses. The drug's action is defined by its ability to modulate specific molecular cascades that influence physiological responses, resulting in a modified functional state within the affected systems.


Modulating Receptor-Mediated Signaling

Decan acts within domains involving receptor-mediated signaling by selectively engaging or inhibiting specific membrane receptors. This engagement modifies early molecular steps, initiating or suppressing the signaling sequences that lead to downstream cellular effects. The resulting physiological effect is the attenuation of heightened physiological signaling driven by excessive receptor activity.


Regulating Enzyme-Dependent Pathways

The drug's mechanism includes the regulation of enzyme-mediated signaling, where it alters the activity of key enzymes within critical biological pathways. This mechanistic intervention modifies pathway activity that may escalate under certain conditions, resulting in the reduction of excessive mediator activity and a shift toward a modified state within the targeted biochemical cascades.

Dosage and Administration Information

How to Use Decan — Official Administration Guidelines

Decan is a concentrated solution used to provide essential trace elements and is administered solely within a healthcare setting as part of total parenteral nutrition (IV feeding).


Administration Scope

Instruction Detail
Route of Administration Intravenous infusion
Preparation Requirements Must not be administered directly. The concentrate must be diluted or mixed into a suitable parenteral nutrition admixture before use.
Standard Daily Dose One 40 mL vial per day (Adults). The maximum recommended daily dose is two vials (80 mL).

Usage Rules and Adjustments

Decan is administered once daily as a continuous component of the nutritional regimen. The medication is not intended for use in pediatric patients or individuals weighing less than 40 kg.

Dose adjustments and special monitoring of specific trace element levels (such as Manganese) are required for certain patient groups, including those with renal impairment or hepatic impairment (liver disease). If monitoring reveals accumulation, the dose must be reduced or administration must be stopped. Since Decan is administered as part of a nutritional regimen, there are no specific missed-dose rules, as its administration is procedural and managed by a healthcare team.

Procedural Structure

The official protocol dictates that the correct dose is added aseptically to the compatible intravenous solution. The solution is then delivered via slow infusion. This procedural structure ensures the trace elements are safely and effectively delivered to support nutritional needs, preventing direct injection of the concentrate.

Recent Clinical Evidence

Research Evidence for Decan (Dexamethasone): Study Overview

The body of research supporting the evaluation of Decan is extensive, drawing primarily from Randomized Controlled Trials (RCTs). These trials, along with systematic reviews and meta-analyses, are relevant in trials assessing short-term or episodic symptom patterns. Research has explored its inclusion in various acute and specific chronic conditions, focusing on outcomes reflecting daily functioning and outcomes monitoring physiological strain.


Evidence in Acute Conditions: Respiratory and Inflammatory Support

Research has primarily focused on what was measured when Decan was included in a treatment protocol for severe, acute inflammatory conditions, particularly those requiring intensive care. Large-scale RCTs were conducted on hospitalized adults and adolescents who required supplementary oxygen or mechanical ventilation. The studies explored time-sensitive outcomes like all-cause mortality at set intervals and the total duration of required mechanical support.

Studies reported measurements describing patterns observed in mortality and recovery time in patients needing respiratory assistance. The research is supported by numerous available trials. It is important to note that results apply only to the populations studied, and data for long-term functional and pulmonary outcomes are not well characterized.


Evidence in Specialized and Supportive Therapeutic Areas

Decan was studied for specific, specialized uses where its use was studied as a component of a larger treatment plan. For conditions like Multiple Myeloma (a blood cancer), evidence stems from historical clinical studies that have explored Decan's inclusion as an agent in multi-agent regimens over many years.

In the case of Macular Edema (swelling in the eye), research was observed in adult patients using specialized delivery systems. Studies reported measurements of visual function and swelling. However, the data is specific to the specialized delivery systems used and may not apply to other administration methods, and comparative evidence is lacking in some contexts.


Areas of Uncertainty and Research Gaps

Significant uncertainty remains due to inconsistent results in some areas, such as the use of Decan to assess Bronchopulmonary Dysplasia (BPD) in preterm infants, where long-term follow-up studies described observations regarding neurodevelopmental status. Additionally, for uses like postoperative pain management, study heterogeneity complicates synthesis, and the long-term effects are not fully established for many acute indications.

Key Studies & References

  1. Dexamethasone in Hospitalized Patients with COVID-19 - Preliminary Report (RECOVERY Trial)
  2. The Effects of Slow-Release Dexamethasone in the Treatment of Diabetic Macular Edema
  3. Label: DEXAMETHASONE tablet - DailyMed - NIH (Used for approved indications and general evidence context)

Frequently Asked Questions (FAQ)

Common questions about Decan (FAQ)


Q: What is Decan used for besides its main listed purpose?

Regulatory documents state that Dexamethasone, the active ingredient in Decan, is approved to treat a broad range of conditions. These uses extend beyond its primary purpose to include specific allergic and inflammatory states, certain types of cancer like Multiple Myeloma, and cerebral edema (swelling in the brain).


Q: Why is Decan sometimes mentioned with other treatment options?

Official information indicates that Decan is often used as one component within a larger treatment regimen. This approach, known as combination therapy, is common in protocols for certain cancers and severe inflammatory conditions. The combination is intended to enhance the overall therapeutic effect of the total regimen.


Q: What makes Decan different from the similar medicines I've seen advertised?

According to the FDA and other regulatory sources, Dexamethasone is chemically distinct from some other similar corticosteroids. It is primarily noted for its high anti-inflammatory potency while having a lesser effect on the body's salt and water balance. This means it has almost no sodium-retaining property compared to some related derivatives.


Q: Is Decan considered a long-term or short-term treatment?

Official classification notes Dexamethasone as a long-acting corticosteroid. While it is frequently used in short courses for acute symptom management, its use over an extended period is associated with certain known risks. Long-term continuous use can potentially lead to suppression of the body’s natural hormone production (HPA axis suppression).


Q: Does Decan have a cumulative effect over time?

Regulatory information suggests that the risk of certain side effects may be related to the total or cumulative dose received over the entire treatment course. Furthermore, the body’s physiological response changes over time, as evidenced by the risk of withdrawal symptoms that can occur following prolonged use.


Q: Can Decan cause me to feel tired or dizzy?

Yes, official product information reports that dizziness and unusual tiredness or weakness (sometimes referred to as fatigue) are known side effects associated with Dexamethasone use. These effects are generally categorized under nervous system disorders.


Q: Are there any specific foods or drinks to be cautious about while using Decan?

Decan can affect the balance of fluids and electrolytes in the body, such as increasing potassium excretion. Due to this potential effect, official warnings highlight that monitoring of salt and potassium levels may be required, and specific dietary measures may be considered by a healthcare professional. Furthermore, the oral solution formulation may contain alcohol as an inactive ingredient.


Q: Is it true that Decan can change the way some vitamins work?

Official information does not contain a general statement about all vitamins. However, drug interaction warnings note that corticosteroids may alter the effects of vitamin K antagonists, a class of medicines linked to vitamin metabolism. Information on all supplements taken should be shared with a healthcare professional.


Q: Is Decan used differently for children compared to adults?

Yes, the official use of Decan in children, particularly neonates, involves specific administration protocols that differ from adult use. Clinical research has examined specific timing and maximum cumulative doses to optimize potential benefits while monitoring for risks such as growth suppression.


Q: Are there any studies looking at Decan's use in the elderly population?

Yes, clinical data is available regarding the use of Dexamethasone in the elderly population. This is reflected in official guidance that includes specific dosage adjustments for patients over 75 years of age in certain treatment regimens.


Q: What were the main findings of the clinical trials for Decan?

Official research findings indicate that studies of Dexamethasone in certain critically ill patient populations reported a decrease in the measured rate of mortality. Studies also focus on specific time-sensitive outcomes, such as the potential to reduce or prevent a serious late-phase reaction in conditions like anaphylaxis.


Q: Is the research on Decan still ongoing?

Yes, official government clinical trial registries show that research is still ongoing for Dexamethasone. New studies are continually evaluating its use for various conditions and exploring different treatment protocols.


Q: What happens if I stop using Decan suddenly?

Regulatory documents warn that stopping Decan suddenly, especially after continuous or high-dose use, can be dangerous. Abrupt discontinuation can lead to withdrawal symptoms and may cause adrenocortical insufficiency (the adrenal glands cannot make enough hormones). Official guidance notes that the dosage must be reduced gradually under medical supervision to mitigate this risk.


Q: Is Decan known to cause dependency or addiction?

The official label cautions that prolonged use of corticosteroids can lead to physical dependence due to the suppression of the body’s natural hormone production (HPA axis). This physiological change means the body relies on the medicine. Emotional dependence has also been observed in rare cases due to reported mood effects.


Q: Is Decan affected by grapefruit juice, like some other medicines?

Dexamethasone is metabolized by a specific liver enzyme (CYP3A4) that can be affected by grapefruit juice. Although an explicit warning may not appear on the drug label, interactions are possible with many medicines that use this enzyme. It is prudent to follow advice regarding food and juice restrictions for any medication.


Q: How is Decan eliminated from the body?

Official pharmacology information states that the drug is eliminated from the body through metabolic clearance. This process occurs primarily in the liver, where the active ingredient is metabolized by the CYP3A4 enzyme. The plasma elimination half-life is typically described as approximately 36 to 72 hours.


Q: Are there any common reasons a doctor might choose Decan over an alternative drug?

Regulatory documents describe Decan's unique profile, which makes it a preferred option in certain contexts. It is known for its high anti-inflammatory potency and extended duration of action. Additionally, it has minimal mineralocorticoid activity, meaning a lesser potential for side effects related to fluid retention or blood pressure elevation compared to some alternatives.


Q: Is there a generic version of Decan available?

Yes, Dexamethasone, the active ingredient in Decan, is available as a generic medication. The generic version contains the same active ingredient and has been verified to work the same way as the brand-name product.


Q: What are the ingredients in Decan besides the active substance?

The non-active ingredients, or excipients, vary depending on the specific formulation (tablet, solution, etc.). For instance, the official oral tablet may contain lactose monohydrate, magnesium stearate, starch, or various coloring agents. A full list of excipients is available in the official product label.


Q: Why does the packaging for Decan include a warning about driving?

Warnings about driving are related to the potential for the medication to cause side effects such as dizziness, vertigo, and mood changes which affect cognitive function. The regulatory advice for many drugs that affect the central nervous system is that mental and physical abilities needed for tasks like driving may be impaired.


Q: Can people who are lactose intolerant use Decan?

Official product information confirms that the oral tablet formulation of Dexamethasone contains lactose monohydrate as an inactive ingredient. Individuals with known lactose intolerance are encouraged to consult a healthcare provider or pharmacist regarding their specific product and its excipients.


Q: Can Decan be taken with herbal supplements?

Regulatory alerts from some agencies have highlighted the risk of specific herbal supplements being illegally contaminated with undeclared Dexamethasone. This poses a significant risk of uncontrolled consumption and adverse side effects. Information regarding all herbal supplements should be shared with a healthcare professional due to potential risks of interaction or safety concerns.


Q: Is Decan classified as a controlled substance in the US?

No, Dexamethasone is classified as a prescription medication. Official classification documents confirm that it is not listed as a controlled substance under the Controlled Substances Act (CSA) in the United States.


Q: Why might a patient feel Decan isn't working for them?

Official regulatory text describes that the body's clearance of Dexamethasone can be accelerated by certain factors. For instance, having an overactive thyroid (hyperthyroidism) or taking certain CYP3A4 inducing medicines can break down the drug faster. This may lead to reduced drug exposure and a feeling that the medicine is not working as expected.


Q: How does Decan compare in its class to other drugs, according to research?

Decan is described in official scientific literature as being a highly potent corticosteroid. It is estimated to be approximately 25 to 30 times more potent than hydrocortisone. Furthermore, it possesses a long biological half-life compared to other members of its drug class.


Q: Can Decan cause changes in mood or sleep patterns?

Yes, the official label reports that Dexamethasone can affect the central nervous system. Psychiatric side effects may include mood swings, emotional instability, depression, or euphoria. Changes in sleep patterns, such as insomnia (trouble sleeping), are also reported.


Q: Can Decan be crushed or mixed with food?

The oral tablet formulation is generally recommended to be taken with food to help reduce the risk of stomach irritation. Since the administration instructions provided relate mainly to the IV concentrate, detailed guidance on modifying the oral tablet (e.g., crushing) is determined by a pharmacist based on the specific product formulation.


Q: What is the half-life of Decan, according to pharmacology texts?

According to official pharmacology texts, the plasma elimination half-life of Dexamethasone in humans is approximately 36 to 72 hours. This duration is a measure of how long it takes for the concentration of the drug in the body to be reduced by half.


Q: Does Decan cause weight changes?

Yes, common side effects reported in official documents include increased appetite and weight gain. These effects are related to the influence of corticosteroids on the body’s metabolism and fat distribution.


Q: Is it necessary to avoid alcohol completely while using Decan?

Regulatory warnings confirm that some oral solution formulations contain alcohol as an inactive ingredient. While a blanket warning to avoid drinking alcohol is not consistently given, it is advised to be cautious. Corticosteroids can increase the risk of gastrointestinal bleeding, a risk that may be heightened by alcohol consumption.


Q: What is the difference between Decan tablets and capsules, if both exist?

According to official product listings, the available oral dosage forms for Dexamethasone are generally limited to tablets and oral solutions. Capsules are typically not listed as a commercially available formulation.


Q: What information should I have ready when discussing Decan with a healthcare provider?

You should be prepared to discuss any history of diabetes or thyroid conditions, as these can affect how the drug works and is monitored. It is also important to provide a complete list of all medications and supplements being taken, along with any existing psychiatric conditions, due to potential interactions and side effects.


Q: Is Decan suitable for use by people with diabetes?

Yes, Decan can be used by people with diabetes, but it requires careful caution and monitoring. Official warnings state that the medication can cause hyperglycemia (high blood sugar). Therefore, patients with known or latent diabetes will likely need adjustments to the required dosage of insulin or other antidiabetic agents.


Q: Are there specific warnings for athletes regarding Decan?

Yes, regulatory bodies for competitive sports have issued specific warnings. Dexamethasone is listed by the World Anti-Doping Agency (WADA) and is generally prohibited for use in athletes during in-competition periods unless they have obtained a specific Therapeutic Use Exemption (TUE).


Q: What is the highest dosage strength of Decan available?

Official regulatory listings confirm that the oral tablet formulation of Dexamethasone is manufactured in strengths up to 6 mg. The oral solution concentrate is also available at a concentration of 1 mg per mL.


Q: Does Decan require any specific tests before starting treatment?

The official label mandates specific monitoring tests during therapy. Additionally, the need to adjust dosage based on factors like thyroid status and existing diabetes implies that a baseline assessment of these and other underlying conditions is necessary before starting treatment to determine the appropriate course of therapy.


Q: What is the standard regulatory approval status of Decan?

Dexamethasone is a long-established medication, having received its initial FDA approval in the United States back in 1958. It maintains its regulatory approval for numerous specific indications where anti-inflammatory and immunosuppressive action is required.

How should Decan be stored and disposed of?

How to Store and Dispose of Decan

Decan (Dexamethasone) must be stored under specific environmental constraints to maintain its stability. The product requires storage at a temperature below 25 C and must not be frozen. To ensure product integrity, the container must be kept in the outer carton to protect from light.

Official Handling and Disposal

Decan must be stored out of the sight and reach of children. Regarding packaging, do not store partly used containers; all equipment must be discarded after use. Disposal of unused or expired Decan must not be via wastewater or household waste. It must be disposed of in accordance with official local regulations, typically requiring guidance from a pharmacist.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Decan found in:

A-Z Index: